Powerock Pharma IGF-LR3 1000mcg
IGF-LR3 (Long Arginine 3) is a synthetic peptide with prolonged action that stimulates tissue growth and regeneration by activating IGF-1 receptors. It increases protein synthesis, supports fat burning, and enhances nutrient transport into cells. Choose Powerock Pharma for the highest quality and consistent research results.
IGF-LR3 1mg
IGF-LR3 (Long Arginine 3-IGF-1) is an advanced synthetic peptide designed for laboratory analysis of cellular growth and regeneration processes. This compound has been developed as a modified form of natural IGF-1 with an additional 13 amino acids in the N-terminal sequence and a substitution of glutamic acid with arginine at position 3. This structural modification (CAS 946870-92-4) significantly extends the half-life to 20–30 hours compared to 12–15 minutes for natural IGF-1, making it approximately 3 times more potent than the natural growth hormone.
IGF-LR3 Powerock Pharma - Research Properties
Discover the research potential of IGF-LR3 in the context of cellular growth and tissue regeneration processes under laboratory conditions.
Muscle Hyperplasia Analysis
Enables the study of processes that increase the number of muscle cells and the development of new fibers.
Protein Synthesis Research
Allows analysis of mechanisms that enhance RNA and protein synthesis while inhibiting their degradation.
Cellular Transport
Enables the study of glucose and amino acid transport into cells under laboratory conditions.
Neuroregeneration
Allows investigation of the impact on neuronal growth and differentiation, as well as neuroprotective functions.
Lipid Metabolism
Enables analysis of lipolysis and fat utilization as an energy source.
IGF-1R Receptors
Allows examination of PI3K-AKT and MAPK signal pathway activation.
Laboratory Standard
Manufactured in compliance with GMP, HACCP, and ISO 13485 standards for maximum purity.
Extended Action
Enables long-term observation of effects thanks to 120-fold longer activity duration.
Mechanism of Action of IGF-LR3 Under Laboratory Conditions
- IGF-1R receptor activation: Studies show strong binding to IGF-1 receptors and activation of key signaling pathways such as PI3K-AKT and MAPK.
- Low affinity to IGFBP: Structural modifications ensure minimal affinity to IGF-binding proteins, extending bioactivity up to 120 times.
- Stimulation of cell proliferation: Observed impact on cell division and differentiation in muscle, bone, and neural tissues.
- Modulation of glucose metabolism: Demonstrated potential in regulating glucose transport and insulin sensitivity in research models.
- Anabolic effects: Significant research potential for analyzing tissue hyperplasia and hypertrophy processes.
Why choose IGF-LR3 from Powerock Pharma?
Powerock Pharma specializes in the production of high-quality peptides for laboratory research. Each IGF-LR3 batch is manufactured in certified laboratories compliant with GMP, HACCP, and ISO 13485 standards. A rigorous quality control system includes mass spectrometry (MW: 9.116 kD) and advanced chromatographic procedures ensuring proper protein folding and maximum biological activity. Collaboration with leading research centers guarantees validation and standardization of every batch. Choosing Powerock Pharma means ensuring consistent results and precision in scientific research.
Research Protocol
Solution preparation:
IGF-LR3 must be dissolved in bacteriostatic water. For accurate concentration calculations, we recommend using the peptide concentration calculator.
Study schedule:
It is recommended to conduct analyses 3 times a week at strictly defined time intervals according to the research protocol.
Experiment duration:
The recommended observation period under laboratory conditions is up to 6–7 weeks with breaks between cycles.
Initial dosage:
Suggested research amount: 10 units (100mcg) 3x/week, modifiable according to protocol.
Pen contents:
One pen contains 100 units of 10 micrograms each (1mg total), sufficient for approximately 3 weeks of research.
Control parameters:
Systematic monitoring of biochemical parameters is necessary, particularly glucose levels and metabolic functions.
Frequently Asked Questions
- In laboratory conditions, it is recommended to start with a concentration of 100mcg (10 units) 3x/week, with the possibility of modification depending on the research protocol and observed reactions.
- Under laboratory conditions, IGF-LR3 can be analyzed alongside other growth peptides, especially in studies of anabolic and regenerative hormone synergy.
- During research, cellular growth parameters, protein synthesis, and metabolic markers should be monitored. Special attention should be paid to the risk of hypoglycemia at high doses.
- IGF-LR3 has been the subject of research cycles lasting up to 45 days. It is recommended to follow protocols with 20–40 day breaks between cycles to avoid desensitization.
- Lyophilized IGF-LR3 should be stored at 2–8°C, away from light and moisture. After reconstitution, it must be stored only in a refrigerator following laboratory standards.
- Powerock Pharma ensures compliance with GMP, HACCP, and ISO 13485 standards. Our procedures include mass spectrometry checks and chromatographic purification techniques, ensuring maximum purity and biological activity of each batch.
Calculator for measuring research doses
Tip: 1 MG = 1000 MCG